These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 841673)

  • 21. Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program.
    Smith KJ; Hodges PA
    Transfusion; 1984; 24(6):520-3. PubMed ID: 6438840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factor VIII concentrate, highly purified and heated in solution (author's transl)].
    Heimburger N; Schwinn H; Gratz P; Lüben G; Kumpe G; Herchenhan B
    Arzneimittelforschung; 1981; 31(4):619-22. PubMed ID: 6788045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of factor VIII concentrates by cryoprecipitate sedimentation.
    Boudart DJ; Naud MF
    Transfusion; 1979; 19(5):594-6. PubMed ID: 505533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Further experimental studies on preparations following a modified method of factor VIII (AHG) isolation by freeze precipitation. II].
    Wegner H; Bergmann A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):320-6. PubMed ID: 4195276
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation.
    Branović K; Gebauer B; Trescec A; Benko B
    Appl Biochem Biotechnol; 1998 Feb; 69(2):99-111. PubMed ID: 9513991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased yield of F VIII from pooled plasma vs. single-donor plasma in the production of cryoprecipitates.
    Rácz Z; Thék M; Jánossy A; Pintér J; Baróti C
    Arch Med Res; 1997; 28(2):179-82. PubMed ID: 9204605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processing.
    Farrugia A; Grasso S; Douglas S; Harrap R; Oates A; Young I; James J; Whyte G
    Transfusion; 1992 Oct; 32(8):755-9. PubMed ID: 1412684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variables involved in cryoprecipitate production and their effect on factor VIII activity. Report of a working party of the Regional Transfusion Directors Committee.
    Br J Haematol; 1979 Oct; 43(2):287-95. PubMed ID: 508637
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of heat treatment on FVIII:C recovery from freeze dried cryoprecipitate.
    Benny AG; Ockelford PA; Johns AS; Scott RH; Woodfield DG; Berry EW
    J Clin Pathol; 1988 Sep; 41(9):945-7. PubMed ID: 3142936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Isolation and some properties of factor VIII (antihemophilic factor)].
    Bykowska K; Lopaciuk S; Michalski R
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation of a cryoprecipitate by the thaw and siphon method].
    Daszyński J; Rosiek A; Lopaciuk S
    Acta Haematol Pol; 1985; 16(3-4):139-43. PubMed ID: 3939069
    [No Abstract]   [Full Text] [Related]  

  • 34. A protocol for cryoprecipitate production.
    Burka ER; Harker LA; Kasper CK; Kevy SV; Ness PM
    Transfusion; 1975; 15(4):307-11. PubMed ID: 1166503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryoprecipitated antihemophilic factor production from blood collected in quad packs or from blood with delayed processing. The importance of plasma thawing method.
    Orthner CL; MacPherson JL
    Transfusion; 1984; 24(6):516-9. PubMed ID: 6438839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet collection during plasma exchange donation of cryoprecipitate.
    McLeod BC; Sassetti RJ; Cole ER; Scott JP
    Prog Clin Biol Res; 1990; 337():481-3. PubMed ID: 2112755
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation of stable intermediate-purity factor VIII concentrate with a note on high-purity factor VIII.
    Margolis J; Rhoades P
    Vox Sang; 1979; 36(6):369-74. PubMed ID: 494575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple method for preparation of good quality cryoprecipitate.
    De M; Banerjee D; Chandra S; Bhattacharya DK
    Indian J Med Res; 1989 Feb; 90():32-5. PubMed ID: 2498203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the 'Mason' (continuous-thaw-siphon) method for cryoprecipitate production.
    Prowse CV; McGill A
    Vox Sang; 1979; 37(4):235-43. PubMed ID: 386613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.